Mark David
BCAL Diagnostics, NSW, Australia
- This delegate is presenting an abstract at this event.
Dr. David is a senior (clinical) scientist with a PhD from Imperial College of London and over 20 years of experience spanning industry and academia. He specializes in small molecule bioanalysis, with a focus on developing and optimizing analytical and bioinformatic workflows for LC-MS-based metabolomics and lipidomics applications. His expertise extends to research, analytical method validation, and knowledge of quality management systems. In addition to his scientific contributions, Dr. David serves as a technical assessor for NATA, ensuring compliance with industry standards.
Presentations this author is a contributor to:
Method validation of the novel breast cancer lipid biomarker assay, BREASTEST plusTM, using liquid chromatography tandem mass spectrometry (#442)
4:00 PM
Mark David
Accepted Posters
AUS-oMicS 2025